The safety and effectiveness of deferiprone in a large‐scale, 3‐year study in Italian patients
- 3 July 2002
- journal article
- clinical trial
- Published by Wiley in British Journal of Haematology
- Vol. 118 (1) , 330-336
- https://doi.org/10.1046/j.1365-2141.2002.03554.x
Abstract
The British Journal of Haematology publishes original research papers in clinical, laboratory and experimental haematology. The Journal also features annotations, reviews, short reports, images in haematology and Letters to the Editor.Keywords
This publication has 21 references indexed in Scilit:
- The Sydney Children's Hospital experience with the oral iron chelator deferiprone (L1)Transfusion Science, 2000
- Safety profile of the oral iron chelator deferiprone: a multicentre studyBritish Journal of Haematology, 2000
- Factors Influencing Effectiveness of Deferiprone in a Thalassaemia major Clinical SettingActa Haematologica, 2000
- Iron Chelation with Oral Deferiprone in Patients with ThalassemiaNew England Journal of Medicine, 1998
- Long-Term Safety and Effectiveness of Iron-Chelation Therapy with Deferiprone for Thalassemia MajorNew England Journal of Medicine, 1998
- Results of long‐term deferiprone (L1) therapy: a report by the International Study Group on Oral Iron ChelatorsBritish Journal of Haematology, 1995
- Iron-Chelation Therapy with Oral Deferiprone in Patients with Thalassemia MajorNew England Journal of Medicine, 1995
- Deferiprone‐associated myelotoxicityEuropean Journal of Haematology, 1994
- Arthropathy in thalassaemia patients receiving deferipronePublished by Elsevier ,1994
- Long‐term assessment of efficacy and safety of L1, an oral iron chelator, in transfusion dependent thalassaemia: Indian trialBritish Journal of Haematology, 1992